These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35474600)

  • 21. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
    Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL
    Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085
    [No Abstract]   [Full Text] [Related]  

  • 22. Focal irreversible electroporation as primary treatment for localized prostate cancer.
    van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
    Rodler S; Danninger D; Eismann L; Kazmierczak PM; Jokisch F; Li M; Becker A; Kretschmer A; Stief C; Westhofen T
    World J Urol; 2024 Apr; 42(1):242. PubMed ID: 38635030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical Outcomes in High-risk Prostate Cancer and Salvage Radical Prostatectomy.
    Avda Y; Modai J; Shpunt I; Dinerman M; Shilo Y; Croock R; Jaber M; Linder U; Leibovici D
    Isr Med Assoc J; 2021 Dec; 23(12):777-782. PubMed ID: 34954916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
    Chade DC; Eastham J; Graefen M; Hu JC; Karnes RJ; Klotz L; Montorsi F; van Poppel H; Scardino PT; Shariat SF
    Eur Urol; 2012 May; 61(5):961-71. PubMed ID: 22280856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
    Van den Broeck T; Oprea-Lager D; Moris L; Kailavasan M; Briers E; Cornford P; De Santis M; Gandaglia G; Gillessen Sommer S; Grummet JP; Grivas N; Lam TBL; Lardas M; Liew M; Mason M; O'Hanlon S; Pecanka J; Ploussard G; Rouviere O; Schoots IG; Tilki D; van den Bergh RCN; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Mottet N
    Eur Urol; 2021 Nov; 80(5):531-545. PubMed ID: 33962808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Heidenreich A; Richter S; Thüer D; Pfister D
    Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
    Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA
    Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments.
    Guenther E; Klein N; Zapf S; Weil S; Schlosser C; Rubinsky B; Stehling MK
    PLoS One; 2019; 14(4):e0215093. PubMed ID: 30986263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results.
    Kaouk JH; Hafron J; Goel R; Haber GP; Jones JS
    BJU Int; 2008 Jul; 102(1):93-6. PubMed ID: 18410443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.
    Yaxley WJ; Gianduzzo T; Kua B; Oxford R; Yaxley JW
    Investig Clin Urol; 2022 May; 63(3):285-293. PubMed ID: 35534217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.
    Marra G; Karnes RJ; Calleris G; Oderda M; Alessio P; Palazzetti A; Battaglia A; Pisano F; Munegato S; Munoz F; Filippini C; Ricardi U; Linares E; Sanchez-Salas R; Goonewardene S; Dasgupta P; Challacombe B; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Smelzo S; Piechaud T; Taille A; Roupret M; Albisinni S; van Velthoven R; Morlacco A; Vidit S; Gandaglia G; Mottrie A; Smith J; Joshi S; Fiscus G; Berger A; Aron M; Abreu A; Gill IS; Van Der Poel H; Tilki D; Murphy D; Lawrentschuk N; Davis J; Gontero P
    Urol Oncol; 2021 May; 39(5):296.e21-296.e29. PubMed ID: 33436329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
    Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
    Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study Protocol.
    Marra G; Shah TT; D'Agate D; Marquis A; Calleris G; Lunelli L; Filippini C; Oderda M; Gatti M; Valerio M; Sanchez-Salas R; Bossi A; Gomez-Rivas J; Conte F; Deandreis D; Cussenot O; Ricardi U; Gontero P
    Front Surg; 2022; 9():900528. PubMed ID: 35747441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
    Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD
    World J Urol; 2021 Apr; 39(4):1107-1114. PubMed ID: 32488359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
    Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
    Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of salvage radical prostatectomy following more than one failed local therapy.
    Sivaraman A; Scardino P; Eastham J
    Investig Clin Urol; 2018 May; 59(3):152-157. PubMed ID: 29744471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review.
    Marra G; Marquis A; Yanagisawa T; Shariat SF; Touijer K; Gontero P
    Eur Urol Focus; 2023 Mar; 9(2):251-257. PubMed ID: 36822924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.